CClinicalTrials.gg
Status unknownNCT04553965CBCTUpdated Sep 18, 2020

Assessment of Alveolar Bone Thickness Buccal to Maxillary Anterior and Premolar Teeth in a Sample of Egyptian Population Using CBCT

An observational study in Alveolar Bone Thickness, sponsored by Cairo University. Status unknown. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2020-09-18.

Sponsored by Cairo University · Observational

The sponsor has not verified this record recently (last verified Sep 2020), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
100
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Tooth loss in an aesthetic area is often undesired experience for the patient. Dental implant offers the most long term solution for missing teeth replacement, replicating the root and crown of the natural tooth. This procedure reserves both the gingival mucosa and the remaining alveolar bone without damage to adjacent teeth.

According to the conventional protocol of dental implant, a period of 3-4 months is required for socket healing, followed by implants insertion, then additional 3-4 months are needed for implant integration with surrounding bone. Moreover, one additional step is required to load the prosthetic abutment. This conventional protocol consumes extended period of time leaving the patient with missing tooth. Many attempts to shorten the overall length of treatment had focused on approaches of immediate or early implant placement especially in the aesthetic zone.

The advantages of the immediate implant placement include, less surgical intervention procedures, so reduction in therapy time, preservation of the bone and gingival tissues, and psychological confidence for the patient. In spite of the advantage of the immediate implant placement, it is still a challenging treatment option for the clinician and presents a higher incidence of complications. It reported that the anatomic factors which influence the outcomes of immediate implant placement at the anterior region are the gingival biotype, the thickness and height of the existing alveolar bone, the amount of bone beyond the apex, and the buccal gap.

Following tooth extraction, high degree of resorption is expected, which is more severe in the buccal alveolar wall thickness. In other words, the bone change is more suspected in the buccal alveolar bone and the palatal alveolar bone is less affected area. Also it was reported that the resorption of the buccal alveolar bone in the anterior are more affected than posterior areas, since the bone resorption is more siginficant where the walls are initially thinner. The vertical and horizontal reduction of bone dimensions is unavoidable. In the first 3 months after dental extraction, this resorption is more noticeable. However, bone remodeling may last for 12 months but less intense, resulting in dimensional change. In some opinions, the buccal alveolar bone thickness should be at least 2 mm to prevent labial gingival recession and to achieve an optimal biologic and esthetic outcome.

Hence in most situations, bone augmentation procedure has been recommended with immediate implant placement in the aesthetic zone.

Recently, several studies have been published discussing if there is enough thickness in the labial alveolar bone for immediate implant placement in an anterior maxillary region. Nevertheless, the existing studies only include anterior teeth. There is not enough research regarding the premolars although they play a role in the aesthetic region.Therefore, this study is designed to investigate the thickness of the buccal alveolar bone of maxillary anterior and premolar teeth in a sample of Egyptian population using Cone beam computed tomography (CBCT) at different levels that are clinically relevant.

Read the detailed description
  • Retrospective Data Analysis will be performed after the CBCT images are pooled from the computer database of "Dokki radiology center"
  • Scans scanned using PaX-i3D Green VATECH with 0.2 voxel resolution will be examined.
  • Exposure parameters of the scans was varied depending on the individual patient's sizes.
  • CBCT images will be analysed using OnDemand3D ® DENTAL (Cybermed, Seoul, Korea) using the 3D module. In the axial plane, the reference line will be oriented to pass through the center of the examined tooth perpendicular to the long axis of the tooth and buccal alveolar bone. The long axis of the tooth will dictate the orientation of the vertical slice. Bone thickness will be measured from the sagittal cross sectional cut where the CEJ will be identified and followed by the measurements in 3 different locations (figure 3): A, 1 mm apical to alveolar crest ; B, 3 mm from the alveolar crest; and C, 5 mm away from alveolar crest.
02

Conditions studied

  • Alveolar Bone Thickness

Keywords

  • CBCT
  • maxillary anterior teeth
  • maxillary premolar teeth
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Egyptian population

Inclusion criteria

  • CBCT scans of adult Egyptian patients, males and females with ages starting from 18.

    • CBCT scans with all maxillary anterior teeth and premolars were present in the assessed quadrant.
    • CBCT images of good quality without artifacts that could interfere with the assessment of the alveolar bone thickness.

Exclusion criteria

Exclusion Criteria:

    • Patients with improper tooth alignment.

      • Patients with bone resorption more than 3 mm
      • Patients with any pathological conditions or lesions affecting the normal bony architecture.
      • Patients with history of chemotherapy or radiotherapy.
      • Patients with dental implant, or endodontic, or prosthetic restoration, or current orthodontic treatment in the maxillary anterior and premolar region.
      • Patients with labial and palatal cleft.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
100 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Assessment of alveolar bone thickness buccal to maxillary anterior and premolar teeth in a sample of Egyptian population using CBCT: An Observational Cross-Sectional Study

    Thickness of the buccal alveolar bone of the maxillary anterior and premolar teeth by cone beam computed tomography in millimeters.In the axial plane, the reference line will be oriented to pass through the center of the examined tooth perpendicular to the long axis of the tooth and buccal alveolar bone. The long axis of the tooth will dictate the orientation of the vertical slice. Bone thickness will be measured from the sagittal cross sectional cut where the CEJ will be identified and followed by the measurements in 3 different locations A, 1 mm apical to alveolar crest ; B, 3 mm from the alveolar crest; and C, 5 mm away from alveolar crest.

    Time frame: 2 years

07

Study locations

No study locations are listed for this record.

08

References and documents

Study documents

  • Study protocol · Sep 6, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 18, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04553965
Lead sponsor
Cairo University
Responsible party
Farid Medhat (assisstant professor of oral and Maxillofacial Radiology, Faculty of Dentistry, Cairo University) — Principal investigator
First posted
Sep 18, 2020
Start date
Oct 15, 2020 (estimated)
Primary completion
May 15, 2021 (estimated)
Completion
Dec 20, 2021 (estimated)
Last update
Sep 18, 2020

Study contacts

farid Medhat, Assistant professor
Contact
farid.medhat@dentistry.cu.edu.eg
01222286816
Arwa Moussa, lecturer
Contact
01224243340

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion